Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients

1 Nov 2018

Abstract excerpt

Background: Hepatocellular carcinoma (HCC) is an aggressive malignancy with high incidence rate and poor prognosis. Enolase-1 (ENO1), a key glycolytic enzyme, has been implicated in the tumorigenesis of various cancers. However, its diagnostic value and clinical significance in HCC are unclear. Methods: Data of 374 HCC tissues and 50 nontumor tissues were retrieved from The Cancer Genome Atlas database, and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Clusterin in disease pathology
Share to S100 Proteins and Annexins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30532594
DOI: 10.2147/cmar.s182183

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patientsPMID 30532594Read ↗

Study on The Expression and Correlation of Alpha-Enolase (Eno1) in The Serum of Patients With Hepatocellular CarcinomaSemantic proximity Read ↗

Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular CarcinomaSemantic proximity Read ↗

Beyond ENO1, emerging roles and targeting strategies of other enolases in cancersSemantic proximity Read ↗

EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patientsSemantic proximity Read ↗

Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular CarcinomaSemantic proximity Read ↗

Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in gliomaSemantic proximity Read ↗

SUMO-Activating Enzyme Subunit 1 (SAE1) is A Promising Diagnostic Cancer Metabolism Biomarker of Hepatocellular CarcinomaSemantic proximity Read ↗

A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1Semantic proximity Read ↗

Exploring the Prognostic Value and Biological Function of CPNE1 Gene in Hepatocellular CarcinomaSemantic proximity Read ↗

Novel candidate biomarkers of origin recognition complex 1, 5 and 6 for survival surveillance in patients with hepatocellular carcinomaSemantic proximity Read ↗

Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinomaSemantic proximity Read ↗

Prognostic implications of alcohol dehydrogenases in hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.